Neuro - ix Flashcards

1
Q

Dx of Myasthenia Gravis is based on

A
  • Clinical features (fatiguable muscles, facial paresis, ptosis, double vision, dysphagia, dysarthria, proximal limb weakness, SOB)
  • Benefit of cholinesterase inhibitors
  • Detection of specific autoantibodies (anti-AChR, anti-MuSK, anti-LRP4)
  • Electrophysiological tests
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ix for Myasthenia Gravis

A
  • Tensilon test
    Gold standard investigation for dx of MG
    Tensilon = edrophonium bromide = short acting anti-cholinesterase
    Given IV - transiently improves muscle weakness by allowing the prolonged action of Ach
    Effects best seen after asking the patient to perform repetitive movements to cause muscle fatigue Generally avoided due to risk of bradycardia

*Serum acetylcholine receptor (AChR) antibodies
First-line investigation

*Muscle-specific tyrosine kinase (MuSK) antibodies
For patients negative for AChR antibodies

  • Low density lipoprotein receptor related protein 4 (LRP4)
  • Blood CK - to exclude myopathies

*Neurophysiological testing on symptomatic muscles
- repeated nerve stimulation
First line ix
Can help establish the diagnosis in seronegative patients with suspected MG
Positive response - >10% decline in compound muscle action potential amplitude bn 1st + 4th potential in a train of 10 stimulations of the motor nerve

*EMG (more sensitive than neurophysiological testing)
Single fibre EMG may demonstrate “jitter” (variability in latency from stimulus to muscle potential between 2 different single motor fibres of the same motor unit) indicating fluctuation in neuromuscular conduction

*CXR
To visualise thymic hyperplasia>thymoma in the mediastinum or malignancies in the lung

*Ice test
Distinguishes MG from other causes of ptosis
Ice on eye for 3 mins leads to improvement of ptosis in pt w MG

*Serum pulmonary function tests
Indicated if SOB or suspected MG crisis
MG crisis: low FVC, negative inspiratory force

Lambert eaton syndorme - anti-voltage gated calcium channel antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ix of meningitis

A

Ix must not delay treatment
* Bloods
2 sets of blood cultures

*Imaging
- CT
Considered before LP if there are signs of increased ICP (focal neurological signs, depressed consciousness)
Reserved for those with specific adverse clinical features or when an underlying cause is suspected e.g. mastoiditis

*LP - most important ix
Dx can only be confirmed by LP + lab examination of the CSF (MCS)
Performed immediately (<1h)
Should be performed before starting abx - definitive diagnosis of causative organism + definitive treatment
CSF
- may be normal in the early stages of meningitis
- repeat if symptoms + signs persist

Contraindications to LP

  • signs of increase ICP (decreased consciousness, bad headache, frequent fits)
  • Coagulopathy
  • focal neurology
  • severe shock
  • sepsis
  • open skin lesion at the site of entry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Results of LP in bacterial/viral/TB meningitis

CSF, neutrophils/lymphocytes, protein, glucose

A

Bacterial

  • Turbid CSF
  • High neutrophils (>500) - polymorphs
  • High protein >1g/L
  • Low glucose <2.2

Viral meningitis

  • Clear/cloudy CSF
  • High lymphocytes 100-500 - mononuclear
  • High/Normal protein <1g/L
  • Normal glucose

TB meningitis

  • Fibrinous CSF
  • High lymphocytes (<1000) - mononuclear
  • High protein 0.1-0.5
  • Low glucose 1.6-2.5
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If pt <16 y/o w unexplained petechial rash + fever

A
  • FBC
  • CRP
  • Coagulation screen
  • Blood culture
  • Whole blood PCR for N. meningitis
  • Blood glucose
  • ABG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CSF in bacterial meningitis

Appearance
Cells
Glucose
Protein

A

Turbid/Cloudy
Increased neutrophils (polymorphs)
Decreased glucose
High protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cushing’s reflex/triad

What is it sign of?

A

Bradycardia
HTN
Irregular breathing

Sign of increased ICP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
CSF in viral meningitis
Appearance
Cells
Glucose
Protein
A

Clear
Increased lymphocytes (mononuclear)
Normal glucose
Normal or increased protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
CSF in TB meningitis
Appearance
Cells
Glucose
Protein
A

Fibrin web
Increased lymphocytes (mononuclear)
Low glucose
High protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Extradural haematoma non contrast CT scan shape

A

Lemon shaped (lentiform)

Does not cross suture lines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Subdural haematoma non contrast CT scan shape

A

Banana shaped (crescent)

Crosses suture lines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SAH ix

A

Urgent non-contrast CT head within 12h

  • Presence of hyperdense appearance of blood in the subarachnoid space/basal cisterns
  • Hyperattenuation around the circle of willis

If CT normal + still suspecting SAH
LP after 12h have passed, examined by spectrophotometry (photospectrometry)
- xanthochromia + oxyhaemoglobin

  • Exclude SAH if both CT + LP are negative
  • CT/MR angiography in pt w confirmed SAH required to identify the cause

• U+Es – hyponatramia is the most common abnormality in SAH, assosciated with SIADH
• Hyperglycaemia – feature of any acute brain injury
• ECG – common cardiac findings in SAH (due to massive catecholamine release resulting in overwhelming sympathetic activation – as a result, transient myocardial ischaemia and failure may occur)
o Arrhythmias + ischaemic changes
o Prolonged QT interval
o ST segment/T-wave abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ischaemia vs haemorrhage on the CT

A

Ischaemia - black

Haemorrhage - white

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Seizure ix

A

EEG
Bloods
Brain imaging (CT, MRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Stroke ix

A

• Non contrast CT head
o First line investigation to differentiate haemorrhagic from ischaemic stroke
o In many cases, the CT is normal within the first few hours of an ischaemic stroke
o Less accurate than MRI for determining the site + extent for ischaemic damage

• MRI brain
o Provides more accurate information about the stroke lesion compared with CT
o Clearly highlights the area of ischaemic infarct
o May provide further clues about the causes

• Serum glucose
o To exclude hypoglycaemia as a cause for focal neurological signs
o Hyperglycaemia has been assosciated with risk of haemorrhagic transformation of ischaemic stroke
o Every pt with TIA or stroke should be screened for DM (fasting plasma glucose, HbA1c, oral glucose tolerance test)

• FBC
o May reveal a cause for arterial occlusion (e.g. polycythaemia vera, thrombocytosis)
o Haemorrhage
o To detect conditions that may be potential contraindications for some acute stroke treatments (thrombolytics, anticoagulants, antithombotics)+ interventions (e.g. anaemia or thrombocytopenia)

• U+Es
o Serum electrolytes - To exclude electrolyte imbalance as a cause for focal neurological signs
o Serum urea + creatinine - Renal failure may be a potential contraindication to some stroke interventions

• Prothrombin time + PTT w INR

• ECG
o Performed to exclude cardiac arrhythmia or ischaemia – relatively common in ischaemic stroke
o AF - potential cause of emboli (fast, irregular, no p-waves)

• Cardiac enymes
o Stroke may be assosciated with concomitant MI

• Carotid duplex US
o In stroke/TIA in carotid territory

• People with acute stroke should have their swallowing screened before being given any oral food, fluid, medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TIA Ix

A

Primary care
• Urinalysis/Serum glucose
o Every pt with TIA or stroke should be screened for DM (fasting plasma glucose, HbA1c, oral glucose tolerance test)
o Hypoglycaemic events can elicit global symptoms e.g. confusion/syncope which can lead to focal symptoms

• FBC
o Polycythaemia, extreme thrombocytosis, extremely high WBC - can contribute to risk of poor cerebral perfusion
o Thrombocytopenia - RF for intracranial haemorrhage

• U+Es
o Severe hyponatraemia can trigger seizures or induce generalised weakness
o Hypokalaemia + hypercalcaemia - can also cause generalised weakness

• Prothrombin time, INR, PTT
o If neurological deficit persists at time of presentation, abnormal coagulation suspected, thrombolytic therapy for stroke is being considered

• ECG (may show AF - RF for embolic cerebral ischaemia, MI, evidence of myocardial ischaemia, HF - RF for atherosclerosis)

• MRI
o To localise infarct, suggest aetiology + distinguish TIA from stroke
o If unavailable, use CT head

• CT!!!
o New focal deficits need to have ischaemia distinguished from haemorrhage Specialist service

  • Doppler US of carotid + vertebral arteries for presence of stenosis
  • Echocardiogram – atrial thrombus, aneurysm of the anterior wall of the LV w mural thrombus, atrial myxoma, L-side valve disease
  • Telemetry/Holter monitor – performed in all patients with TIA to evaluate for AF and other arrhythmias
  • ESR if suspecting giant cell arteritis

If a patient is on warfarin/a DOAC/ or has a bleeding disorder and they are suspected of having a TIA, they should be admitted immediately for imaging to exclude a haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the ABCD2 score?

A

Identifies patients at high risk of stroke following TIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does he ABCD2 score include?

A

Age 60+ (1)
BP SBP 140+ or SBP 90+ (1)

Clinical features - speech disturbance with no weakness (1), unilateral weakness (2)
Duration of symptoms - <10min (0), 10-59mins (1), 60+ min (2)
Diabetes (1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a significant ABCD2 score?What does it mean?How do you manage the risk?

A

4+

High risk of stroke following a TIA

Aspirin 300mg daily
Admit for inpatient assessment regarding suitability for carotid entarterectomy
Secondary prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hydrocephalus ix

A

• CT – first line
o Dilated lateral + 3rd ventricle with:
 N 4th ventricle – aqueduct stenosis
 Abnormal 4th ventricle – posterior fossa mass
o General ventricular dilation – communicating hydrocephalus
o May also pick up cause (e.g. tumour)

• LP – performed after confirming with imaging that hydrocephalus is communicating
o To measure pressure of the CSF
o May suddenly relieve symptoms – Therapeutic in NPH [this is considered diagnostic – if pt’s symptoms relieved by LP, he probably has hydrocephalus]
o Contraindicated if increased ICP

• CSF
o From ventricular drain/LP
o May indicate pathology (e.g. TB)
o MC+S, protein glucose

• Levodopa challenge – ordered in all patients w suspected PD
o Pt given therapeutic trial of levodopa + asked to note improvement in gait symptoms – if symptoms are responsive, then NPH can be ruled out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Multiple sclerosis ix MS

A

MRI

  • Dissemination in time + space of lesions typical of MS
  • Areas of focal dissemination seen as plaques in the optic nerve, brainstem, spinal cord
  • Gadolinium contrast (GAD) - lights up new lesions, old lesions remain dark (proves dissemination in time)

LP

  • CSF
  • Oligoclonal bands (dark bands on protein gel) unmatched with serum
  • Rise in total protein + IgG ab in CSF (CSF ab need to be matched with serum - do they origniate in the CSF or are they features of a systemic immune response?)

Electrophysiology

  • Can detect dissemination
  • Visual evoked potential should be the first choice to confirm dissemination (delayed activation of visual cortex in response to visual stimulation suggests lesion along the optic pathway - ?optic neuritis)
22
Q

4 diagnostic pointers in MND

A
  • Asymmetrical distal weakness
  • Brisk reflexes in a wasted limb
  • Absence of major sensory symptoms and pain
  • Progression of symptoms and signs
23
Q

MND ix

A

No specific ix to confirm dx
• EMG
- Fibrillation, Fasciculations
- Features of acute + chronic denervation with giant motor unit action potentials in 1+ limb and/or paraspinals

• NCS (Nerve conduction studies) - Normal motor + sensory conduction

• CT +/or MRI of brain + spinal cord
o To exclude other pathologies with similar presentations (e.g. cord or root compression, brainstem lesion in progressive bulbar palsy variant)

• Blood tests
o To exclude other conditions
o B12, folate levels, HIV serology, Lyme disease serology, creatine kinase assay, serum protein electrophoresis, anti-GM1 antibodies

• Muscle biopsy
o To exclude or diagnose myopathic conditions

24
Q

Antibodies implicated in MG

A

AChR
Muslce-specific receptor tyrosine kinase
LDL receptor related protein 4
Can also be seronegative

25
Q

3 diagnostic pointers to Multiple Sclerosis

A
  • Absence of alternative diagnosis
  • Dissemination in space
  • Dissemination in time
26
Q

Fundoscopy on a pt with GCA with a sudden loss of vision

A

Cherry red spot

GCA is a form of vasculitis affecting large + medium vessels
In GCA, visual loss is due to occlusion of the ciliary + central retinal arteries –> retina becomes pale due to retinal artery infarction
But the macula receives its blood supply from the choroid (supplied by posterior ciliary arteries) so it appears as a cherry spot on the pale retina

27
Q

Karyotyping ix used for

A
  • Aneuploidy (e.g. Down’s syndrome)

- Translocation disorders

28
Q

Criteria for performing a CT head scan within 1h of the RF being identified for adults who have sustained a head injury and have the following risk factors (7)

A
  • GCS <13 on initial assessment in ED
  • GCS <15 at 2h after the injury assessment in ED
  • Suspected open/depressed skull fracture
  • Any sign of basal skull fracture (haemotympanum, panda eyes, CSF leakage from ear or nose, Battle’s sign)
  • Post-traumatic seizure
  • Focal neurological deficit
  • More than 1 episode of vomiting
29
Q

Adults with any of the following RF who have experienced some loss of consciousness or amnesia since the injury, perfrom a CT head within 8h of the head injury

A

> 65 Hx of bleeding/clotting disorders
Dangerous mechanism of injury
30 mins retrograde amnesia of events immediately before the head injury

30
Q

GBS ix

A

• Nerve conduction studies
o Most useful confirmatory test
o Slowing of nerve conduction velocities
Slowed motor conduction speed (destruction of the myelin sheath)
+/- conduction block (destruction of the axon in severe inflammation) - irreversible damage

• LP – albuminocytological dissociation
o CSF: Increased protein, N glucose, N cell count
o May be normal within the first week of the illness, so you will need to repeat

• Ab screen
o Ab to central + peripheral nerves
o Antiganglioside antibody in Miller-Fisher variant + 25% of Guillaine-Barre cases
o Used if diagnosis remains unclear despite clinical examination, CSF analysis and electrodiagnostic tests

• Spirometry every 6h
o FVC to determine need for admission to ICU + need for intubation
o ICU monitoring + intubation if – Vital capacity <20mL/kg or drop of 30% in vital capacity

• Electrolytes
o SIADH occurs in some patients

• Cardiac monitor
o Need to watch for autonomic neuropathy

31
Q

Trigeminal neuralgia ix

A

• Diagnosis is clinical
o Unilateral, recurrent brief paroxysmal attacks of pain, confined to >1 divisions of the trigeminal nerve
o Pain is invariably described as intense, sharp, stabbing or electric shock like
o At least 3 attacks which have been initiated by triggers
o Successive attacks in the same persons are stereotypical
o No clinical evidence of neurological abnormalities
o Either idiopathic or induced by vascular compression: cannot attributed to any other disorder

• How to differentiate from temporal arteritis
o TN rarely affects the forehead alone

• MRI indicated to rule out other potential causes of pain if the diagnosis is uncertain or if red flags are present
Red flags
o Sensory changes, deafness, ear problems
o Difficult to control pain
o Hx of skin/oral lesions that could lead to perineural spread
o Ophthalmic division only or bilateral (can suggest benign/malignant lesions or MS)
o Age of onset <40 y/o
o Optic neuritis
o FHx of MS

32
Q

Encephalitis ix

A

• CSF PCR
o First line
o For common viral causes of encephalitis (HSV 1+2, VZV, enteroviruses) as a first line screen and subsequent targeted PCRs for additional viruses based on the RF, exposure, clinical picture

• CSF analysis
o Colour – usually clear, can be xanthochromic/blood stained in necrotising + haemorrhagic encephalitis
o Results will depend on whether the cause is viral or bacterial

• CSF serology
o Required for definitive diagnosis
o Elevated CSF specific antibody levels relative to serum indicate CNS infection with the respective organism
(o Compares CSF to serum specific antibody levels in reference to total CSF, serum albumin or total immunoglobulin)

• MRI
o Preferred over CT
o HSV produces characteristic oedema of the temporal lobe

• EEG
o Background slowing slow wave activity
o Temporal lobe epileptiform activity (spoking activity) frequently seen in viral encephalitides
o More useful than CT scan in the first week

•	CSF culture
o	Useful in identifying bacterial + fungal aetiologies
o	Only useful for a few viruses 
o	Acid fast stain – TB
o	India ink – cryptococcus 

• CT
o Should be ordered in all patients with altered mental state
o Rules out SOL, strokes, basilar skull fractures, ICP
o Frequently normal early in the clinical course of encephalitis, may see more prominent changes

• U+Es – SIADH may occur – ?hyponatraemia

Routine work up of a febrile illness
•	Blood cultures - ?malaria
•	Throat swab
•	Sputum culture
•	CXR
33
Q

Indications for LP (4)

A

2/4 are present

  • Headache
  • Fever
  • Meningism
  • Altered mental status
34
Q

Contraindications to LP (6)

A
  • Increased ICP
  • Coagulopathy
  • Open Skin lesion at the site of entry
  • Focal neurological signs
  • Severe Shock
  • Sepsis
35
Q

BPPV ix

A

• History

• Positive Dix-Hallpike/Nylen-Barany manoeuvre – posterior canal BPPV
o Positive test – reproduction of vertigo + nystagmus
o Nystagmus - Torsional – L ear has a clockwise torsional nystagmus response, R ear has an anti-clockwise response, horizontal nystagmus suggests horizonal canal

BPPV

  • Reversible with seating
  • Fatigable with repeat testing
  • Occurs with 1-5s latency- Lasts <30s

• Positive supine lateral head turn – lateral/horizontal canal BPPV
o Positive test – vertigo and nystagmus
o Horizontal nystagmus without torsional component
o When head is rotated towards the affected side the nystagmus will beat towards the ground (geotropic + be more intense)

  • Normal neurological examination
  • Normal ontological examination
36
Q

Meniere’s ix

A

• Condition diagnosed on the basis of the following three factors
o Clinical features
o Audiometric findings
o Exclusion of other causes

Detailed autological tests
• Pure-tone air and bone conduction with masking
o Basic measurement of hearing sensitivity + integrity of the entire auditory receptive pathway
o Air conduction - headphones // bone measurements - attempt to by-pass the outer + middle ear + test function of the cochlea + the auditory nerve
o In Meniere’s air conduction = bone conduction - underlying pathology is in the cochlea or auditory nerve not the outer and the middle ear
o Unilateral sensorineural hearing loss
o Initially worse in the low frequencies

• Probable Meniere’s / Definite Meniere’s also includes *
o >2 spontaneous episodes of vertigo each lasting 20mins-12h
o Fluctuating aural symptoms (hearing, tinnitus, fullness) in the affected ear
o Not better accounted for by another vestibular diagnosis
o *Audiometrically documented low- to medium- frequency sensorineural hearing loss in one ear, defining the affected ear on at least one occasion before, during or after one of the episodes of vertigo

37
Q

Neurofibromatosis ix (10)

A

• Physical exam focused on skin, eyes, ears

• XRAY if
o There are possible modelling defects of the long bones or ribs
o There is concern that a bony lesion may be adjacent to a plexiform neurofibroma
o Scoliosis is seen on clinical examination
o Bone pain exists

• CT, MRI
o Optic pathway gliomas
o Brain tumours
o Hydrocephalus
o Paraspinal neurofibromas
o Malignant peripheral nerve sheath tumours
o Tumours in brain, cranial nerves, spinal cord

• PET scan
o To distinguish malignant peripheral nerve sheath tumour from benign neurofibromas
o To also ix all of the above in CT, MRI

• Biopsy
o To confirm dx of NF1 in pt with only café-au-lait spots
o To distinguish malignant peripheral nerve sheath tumour from benign neurofibromas

  • Slit lamp examination - Lisch nodules
  • Visual evoked potentials – helpful in detecting optic nerve gliomas or assessing tumour progression with optic pathway tumours
  • Hearing tests - test the hearing + vestibular function
  • Genetic testing - to confirm NF1 or NF2 mutation
  • EEG – if seizures occur
38
Q

Huntington’s disease ix

A

1st line investigations to order
• No initial Investigations to consider

• CAG repeat testing
o To confirm the diagnosis
o No Huntington’s disease: >35 CAG
o <28 repeats is a normal result
o 29-35 repeats – normal but the expanded CAG repeat will not result in disease in the patient but is within a range that could expand sufficiently to result in disease in offspring
o 36-39 CAG repeats - abnormal but may develop symptoms of Huntington’s disease or may remain asymptomatic
o All patients with >40 CAG repeat lengths develop Huntington’s
o The longer the repeat length, the earlier the symptoms develop
o The tendency for expansion of CAG repeat in successive generations (anticipation) puts offspring at higher risk for earlier onset of disease than their parents
o Positive result –> >40 CAG repeats on 1 of the 2 alleles
o Intermediate result –> 36-39 repeats

• MRI/CT scan – unhelpful for the dx in early disorder (chronic neuro meded lecture for pics)
o Caudate or striatal atrophy may be apparent but is not specific
o Increased size of frontal horns of the lateral ventricles
o Global atrophy as disease progresses

• Testing for alternative causes of movement disorders (SLE, antiphospholipid antibody syndrome, thyroid disease, Wilson’s disease) and dementia

39
Q

Parkinson’s disease ix

A

• Dx almost entirely based on clinical examination

• NICE recommends using the UK PD Society Brain Bank Criteria for dx
o Step 1: dx of Parkinsonian syndrome (bradykinesia and at least one of: muscular rigidity, resting tremor, postural instability not caused by primary visual, vestibular, cerebellar or proprioceptive dysfunction)
o Step 2: exclusion criteria for PD (exclude other ddx)
o Step 3:supportive prospective positive criteria for PD – >3 required for the dx of definite PD
 Unilateral onset
 Persistent asymmetry affecting the side of onset most
 Rest tremor present
 Progressive disorder
 Hyposmia
 Visual hallucinations
 Excellent response to L-dopa
 Severe L-dopa induced chorea
 L-dopa response for >5 years
 Clinical course of >10 years

• Dopaminergic agent trial
o Performed if dx is in question
o Useful to confirm dx
o L-dopa will cause an improvement in symptoms

  • Other investigations focus on excluding other causes of the presentation
  • A DaTscan can show loss of dopaminergic neurones, implying a neurodegenerative disease such as PD. Parkinson’s disease does not cause abnormalities on CT or MRI imaging
40
Q

Mononuclear visual loss

A

Lesion in the optic nerve

41
Q

Homonymous hemianopoia

A

Lesion in the occipital lobe

42
Q

Bitemporatal hemianopoia

A

Lesion in the optic chiasm

43
Q

Fatiguability - where is the lesion

A

NMJ

44
Q

CHA2DS2-VASc + HAS-BLED score interpretation

A

With a CHA2DS2-VASc score of 2 anti-coagulation is indicated unless the HAS-BLED score is >3

45
Q

Pointers to whether the stroke is ischaemic or hemorrhagic

A

Ischaemic pointers: carotid bruit, AF, past TIA, IHD

Haemorrhagic pointers: meningism, severe headache
Hemorrhagic strokes tend to occur in younger patients with HTN + FHx (pointing to an anatomical anomaly)

Ischaemic more common than hemorrhagic
But you need imaging to distinguish between the 2

46
Q

Subsequent testing after stroke

A

o Carotid doppler
If >50% occlusion of carotid artery –> carotid endarterectomy
o CT angio
Performed in all patients with acute ischaemic stroke with suspicion of a large vessel occlusion who would be candidates for endovascular thrombectomy

47
Q

Epilepsy ix

A

Clinical dx
- Need 2 or more unprovoked seizures occuring >24h apart

EEG

  • To diagnose + localise ongoing seizure activity
  • GTCS - bihemispheric, synchronous epileptiform activity
  • Immediately after the seizure - slowing of background elements diffusely, loss of normal architecture, dampened reactivity
  • Secondary generalisation (focal seizure becomes generalised seizure) - asymmetry, increased suppression + slowing over the hemisphere where the seizure originated

Bloods

  • Exclude hypoglycaemia
  • FBC (evaluate systemic or CNS infection)
  • U+Es (electrolyte disturbances can cause seizures)
  • Serum prolactin (transiently elevated following seizures)
  • ABG taken during or just after the seizure will often show metabolic acidosis which will normalise rapidly
  • Toxicology screen (blood/urine)

Imaging
- CT/MRI
Structural lesions which could have precipitated the seizure

48
Q

Spinal cord compression
Cauda equina syndrome
Radiculopathy

ix

A

MRI

In spinal cord compression also do
• Bloods
o FBC
o U+Es
o ESR
o Calcium (multiple myeloma)
o Immunoglobulin electrophoresis (multiple myeloma)
• Urine – Bence Jones protein (multiple myeloma)
Multiple myeloma can cause spinal cord compression due to pathological fractures or extension of a vertebral body myeloma lesion

49
Q

Diagnosis of migraine

A

SULTANS

2/4 of
Severe
UL Unilateral
Throbbing
Activity provokes pain

1/2 of
Nausea
Sensitivity to light or sound

there might not be an aura

50
Q

Brain tumour ix

A

CT (quicker)
MRI (better resolution)
Biopsy (definitive)

Staging
CXR
CT TAP

51
Q

NPH ix

A
  • LP to show normal CSF opening pressure

- CT/MRI to show dilated ventricles

52
Q

Syringomyelia ix

A

MRI